healthday14d
FDA Approves More Broadly Protective Meningococcal Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...
WebMD15d
FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
Feb. 18, 2025 – The FDA has approved a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD) in people ages 10 to 25 years. Sold as Penmenvy ...
Essential vaccinations for UAE residents travelling to Saudi Arabia for Umrah
Dubai: UAE residents planning to travel to Saudi Arabia for Umrah or to visit cities such as Medina, Jeddah, or Taif must ensure they receive the required vaccinations well in advance. The UAE’s ...
BioPharma Dive15d
GSK’s 5-in-1 meningococcal shot wins FDA approval
The Food and Drug Administration on Friday gave a green light to a new meningococcal vaccine from GSK. Dubbed Penmenvy, the “5-in-1” shot is approved for people aged 10 through 25 years old and ...
Morningstar16d
PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
The vaccine targets five major serogroups of Neisseria meningitidis (A, B, C, W, and Y) which commonly cause invasive meningococcal disease (IMD).1,2 Tony Wood, Chief Scientific Officer, ...
Nasdaq16d
FDA Approves GSK's Penmenvy, 5-in-1 Meningococcal Vaccine For MenABCWY Protection
(RTTNews) - GSK plc (GSK, GSK.L) announced that the US Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...
Healio16d
FDA approves GSK’s pentavalent meningococcal vaccine
Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent ...
BioSpace16d
PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
Building on our global leadership in meningococcal vaccination and our longstanding commitment to address unmet need in disease prevention, we aim to help protect more teens and young adults at a life ...
contemporarypediatrics16d
Reacting to the meningococcal ABCWY vaccine approval with Donna Hallas, PhD, PPCNP-BC
Nurse practitioner Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN offers her thoughts on the recent FDA approval of GSK's meningococcal ABCWY vaccine. On February 14, 2025, the FDA approved ...
contemporarypediatrics18d
FDA approves GSK's meningococcal ABCWY vaccine
The combination vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, AND Y) that cause the most invasive meningococcal disease cases (IMD) globally. The FDA has approved ...
The First In China! BLA Submitted For Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected To Be Launched In 2026
The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...
Medscape24d
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
MCC vaccination has had important consequences for meningococcal population biology, and carriage studies were essential in measuring these effects. The potential for herd immunity should be taken ...